COSM: financial statements from SEC — TradeAlmanac

COSM

Cosmos Health Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Revenue	18m	17m	15m	14m	12m	13m
Cost of revenue	17m	15m	14m	12m	11m	12m
Gross profit	1m	3m	1m	2m	1m	767,248
Research and development	0	18,337	74,637	15,629	0	0
Selling, general and administrative	2m	2m	1m	1m	2m	1m
Operating expenses	4m	4m	4m	3m	3m	3m
Operating income	−2m	−2m	−3m	−833,145	−2m	−3m
Interest expense	423,229	669,150	388,814	187,107	181,429	342,446
Pre-tax income	−3m	−5m	−3m	−818,097	−2m	−3m
Income tax	0	0	0	0	0	0
Net income	−3m	−5m	−3m	−818,097	−8m	−3m
Earnings per share	−0.06	−0.17	−0.10	−0.03	−0.45	−0.15
Earnings per share, diluted	−0.06	−0.17	−0.10	−0.03	−0.45	−0.15
Weighted average shares	47m	31m	29m	26m	18m	18m
Weighted average shares, diluted	47m	31m	29m	26m	18m	18m

Balance sheet

Metric	Mar 31, 2026	Dec 31, 2025	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024
Cash and equivalents	514,702	715,674	889,441	655,503	742,881	315,105	3m	343,509
Short-term investments	34,225	46,158

Cash flow

Metric	Mar 31, 2026	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Sep 30, 2024	Jun 30, 2024
Operating cash flow	−1m	—	—	−186,316	—	—
Depreciation and amortisation	346,520	377,911	353,862	320,439

Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)